249 related articles for article (PubMed ID: 17697391)
21. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
[TBL] [Abstract][Full Text] [Related]
22. The molecular pathology of hereditary breast cancer.
Palacios J; Robles-Frías MJ; Castilla MA; López-García MA; Benítez J
Pathobiology; 2008; 75(2):85-94. PubMed ID: 18544963
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.
Lewis AG; Flanagan J; Marsh A; Pupo GM; Mann G; Spurdle AB; Lindeman GJ; Visvader JE; Brown MA; Chenevix-Trench G;
Breast Cancer Res; 2005; 7(6):R1005-16. PubMed ID: 16280053
[TBL] [Abstract][Full Text] [Related]
24. Molecular and pathological characterization of inherited breast cancer.
Borg A
Semin Cancer Biol; 2001 Oct; 11(5):375-85. PubMed ID: 11562180
[TBL] [Abstract][Full Text] [Related]
25. BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin.
Pageau GJ; Hall LL; Lawrence JB
J Cell Biochem; 2007 Mar; 100(4):835-50. PubMed ID: 17146760
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
[TBL] [Abstract][Full Text] [Related]
27. Expression of BRCA1 and BRCA2 in male breast cancers and gynecomastias.
Bernard-Gallon DJ; Déchelotte PJ; Le Corre L; Vissac-Sabatier C; Favy DA; Cravello L; De Latour MP; Bignon YJ
Anticancer Res; 2003; 23(1B):661-7. PubMed ID: 12680164
[TBL] [Abstract][Full Text] [Related]
28. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.
Anagnostopoulos T; Pertesi M; Konstantopoulou I; Armaou S; Kamakari S; Nasioulas G; Athanasiou A; Dobrovic A; Young MA; Goldgar D; Fountzilas G; Yannoukakos D
Breast Cancer Res Treat; 2008 Jul; 110(2):377-85. PubMed ID: 17902052
[TBL] [Abstract][Full Text] [Related]
29. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression.
Chen X; Truong TT; Weaver J; Bove BA; Cattie K; Armstrong BA; Daly MB; Godwin AK
Hum Mutat; 2006 May; 27(5):427-35. PubMed ID: 16619214
[TBL] [Abstract][Full Text] [Related]
30. Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.
Evans DG; Young K; Bulman M; Shenton A; Wallace A; Lalloo F
Clin Genet; 2008 Apr; 73(4):338-45. PubMed ID: 18312450
[TBL] [Abstract][Full Text] [Related]
31. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
Hartikainen JM; Kataja V; Pirskanen M; Arffman A; Ristonmaa U; Vahteristo P; Ryynänen M; Heinonen S; Kosma VM; Mannermaa A
Clin Genet; 2007 Oct; 72(4):311-20. PubMed ID: 17850627
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
[TBL] [Abstract][Full Text] [Related]
33. A recurrent mutation in PALB2 in Finnish cancer families.
Erkko H; Xia B; Nikkilä J; Schleutker J; Syrjäkoski K; Mannermaa A; Kallioniemi A; Pylkäs K; Karppinen SM; Rapakko K; Miron A; Sheng Q; Li G; Mattila H; Bell DW; Haber DA; Grip M; Reiman M; Jukkola-Vuorinen A; Mustonen A; Kere J; Aaltonen LA; Kosma VM; Kataja V; Soini Y; Drapkin RI; Livingston DM; Winqvist R
Nature; 2007 Mar; 446(7133):316-9. PubMed ID: 17287723
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line.
Pignatelli M; Cocca C; Santos A; Perez-Castillo A
Oncogene; 2003 Aug; 22(35):5446-50. PubMed ID: 12934104
[TBL] [Abstract][Full Text] [Related]
35. Lessons learned from BRCA1 and BRCA2.
Zheng L; Li S; Boyer TG; Lee WH
Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
[TBL] [Abstract][Full Text] [Related]
36. The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity.
Ostrow KL; McGuire V; Whittemore AS; DiCioccio RA
Cancer Genet Cytogenet; 2004 Sep; 153(2):177-80. PubMed ID: 15350310
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 is differentially expressed in human tumor cells.
Meng QH; Yuan RQ; Goldberg ID; Rosen EM; Fan SJ
Shi Yan Sheng Wu Xue Bao; 2001 Mar; 34(1):55-64. PubMed ID: 12549011
[TBL] [Abstract][Full Text] [Related]
38. BRCA1 gene in breast cancer.
Rosen EM; Fan S; Pestell RG; Goldberg ID
J Cell Physiol; 2003 Jul; 196(1):19-41. PubMed ID: 12767038
[TBL] [Abstract][Full Text] [Related]
39. Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer.
Karppinen SM; Erkko H; Reini K; Pospiech H; Heikkinen K; Rapakko K; Syväoja JE; Winqvist R
Eur J Cancer; 2006 Oct; 42(15):2647-52. PubMed ID: 16930991
[TBL] [Abstract][Full Text] [Related]
40. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.
Winter SL; Bosnoyan-Collins L; Pinnaduwage D; Andrulis IL
BMC Cancer; 2007 May; 7():85. PubMed ID: 17511879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]